B+
Bull case
20%
Probability
Target price
$31.50
Analysis reference price unavailable
Analysis 2026-05-21 · RankAlpha Sentiment Codex
AMN
AMN Healthcare ServicesDNYSE / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$22.50
Analysis reference price unavailable
Analysis 2026-05-21 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$16.50
Analysis reference price unavailable
Analysis 2026-05-21 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-05-21
Recent news sentiment (30D)
0.0
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+23.4
Score
AI commentary
Primary-source evidence is strong and the May 7, 2026 print was clearly better than expected, but the market still has to digest a softer Q2 outlook and the fact that much of Q1 strength came from labor-disruption revenue and timing-related deposits. Recent coverage points to a positive but not euphoric reaction, and analyst revisions appear limited so far; that keeps this in monitoring mode rather than a high-conviction bullish call.
RankAlpha Sentiment Codex - 2026-05-21
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-07catalystQ1 beat and Q2 guide reset the near-term setupHigh impact
AMN reported Q1 2026 revenue of $1.378 billion and adjusted diluted EPS of $2.10, both above guidance, and set Q2 revenue guidance of $620-$635 million; management also said travel nurse volume and revenue grew year over year for the first time since 2022 [#8-K-2026-05-07].
2026-06-30eventLabor-disruption revenue should normalize after a timing-heavy quarterMedium impact
Labor disruption events contributed $722 million of Q1 revenue and $367 million of quarter-end client deposits, so part of the quarter's strength was timing-driven and likely to unwind over the next few months [#8-K-2026-05-07].
2026-12-31catalystDurable rerating still depends on competitive share and mix gainsHigh impact
The 2025 10-K describes a highly competitive healthcare staffing and workforce-solutions market with direct rivals including Amergis, Aya Healthcare, CHG Healthcare Services, Cross Country Healthcare, HealthTrust Workforce Solutions, Ingenovis Health, Jackson Healthcare, LanguageLine Solutions, and Medical Solutions; that suggests the stock needs sustained share and mix gains rather than one-quarter event revenue to justify a higher multiple [#10-K-2026-02-20].
Recommendation
N/A
No formal recommendation provided.
As of 2026-05-21 • Updated nightlySource: Internal modelMethodology